Latest Cash Flow News

Cokal Limited has formalised a US$7 million coal prepayment and offtake facility with Cratus Group, marking a pivotal step in accelerating coal production and infrastructure development in Central Kalimantan, Indonesia.

Bioxyne Limited reports a remarkable 77% revenue increase in Q2 FY2025 alongside positive operating cash flow, setting the stage for international growth with upcoming UK export approvals and a planned European GMP facility.

Australian Oil Company Limited has secured an increased consideration in its Red Earth Assets divestment, receiving A$660,000 upfront while deferring A$540,000 to March 2025.

Metro Mining Limited delivered record bauxite shipments in Q4 2024, alongside a successful debt restructure and strong EBITDA margins, positioning the company for growth amid rising market prices.

A1 Investments & Resources Ltd reported minimal cash flow activity for the December 2023 quarter while actively pursuing renewable energy acquisition opportunities in Japan and Australia.

Rox Resources has advanced its Youanmi Gold Project with a $27 million capital raise and a major drilling campaign, positioning the company for production by late 2025.

Empire Energy Group Limited reported a significant cash outflow of $14.2 million in the December 2024 quarter, driven by exploration and evaluation activities, yet maintains a strong liquidity position with nearly $54 million in available funding.

Felix Group Holdings has reported a second consecutive quarter of positive operating cash flow alongside strong customer acquisition and contract expansions, notably within the mining and resources sector.

De.mem Limited has delivered its second highest quarterly cash receipts ever alongside positive operating cash flow for the December 2024 quarter, marking a milestone full-year cash flow turnaround and setting the stage for continued growth in 2025.

Sprintex has locked in A$30 million in distribution agreements across the UK, Turkiye, and India, while advancing its innovative G25 Jet Blower launch, signaling a strong growth trajectory in energy-efficient technologies.

Dimerix Limited has inked a lucrative licensing agreement with Fuso Pharmaceutical for its kidney disease drug DMX-200 in Japan, while completing recruitment for its pivotal Phase 3 ACTION3 trial.

Vection Technologies has reported a milestone positive net cash flow in its traditionally weak quarter, driven by a 60% half-on-half revenue surge and strategic acquisition integration.